17-29074834-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_078471.4(MYO18A):c.6101G>A(p.Arg2034Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_078471.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO18A | NM_078471.4 | c.6101G>A | p.Arg2034Gln | missense_variant | 42/42 | ENST00000527372.7 | NP_510880.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO18A | ENST00000527372.7 | c.6101G>A | p.Arg2034Gln | missense_variant | 42/42 | 1 | NM_078471.4 | ENSP00000437073 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000129 AC: 32AN: 247982Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134660
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461694Hom.: 0 Cov.: 30 AF XY: 0.000118 AC XY: 86AN XY: 727130
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.6101G>A (p.R2034Q) alteration is located in exon 42 (coding exon 41) of the MYO18A gene. This alteration results from a G to A substitution at nucleotide position 6101, causing the arginine (R) at amino acid position 2034 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at